newsfilter
← Latest News
GlobeNewswire·

TransCode Therapeutics Open Letter to Shareholders

BOSTON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The Board and Management of TransCode Therapeutics (NASDAQ:RNAZ) today issued the following open letter to shareholders of the Company: Dear Shareholders, At our upcoming